Gary Taylor
Stock Analyst at TD Cowen
(2.59)
# 2,146
Out of 5,242 analysts
148
Total ratings
51.52%
Success rate
0.8%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $24.92 | +0.32% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $16.11 | +160.71% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $10.49 | +19.16% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $150 → $50 | $88.20 | -43.31% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $310.55 | -13.70% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $16.36 | -20.54% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $404.69 | +8.73% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $389.24 | +56.46% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $59.15 | +50.46% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $184.38 | +105.01% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $166.45 | +32.17% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $194.61 | -22.92% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $23.30 | +11.61% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $13.69 | +155.66% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $402.27 | +45.42% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $24.52 | -75.53% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $7.73 | +3.49% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $291.28 | +12.95% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $3.50 | -14.29% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $7.21 | +135.78% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $191.40 | -89.55% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $23.01 | -13.08% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.80 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $24.92
Upside: +0.32%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $16.11
Upside: +160.71%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $10.49
Upside: +19.16%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $150 → $50
Current: $88.20
Upside: -43.31%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $310.55
Upside: -13.70%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $16.36
Upside: -20.54%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $404.69
Upside: +8.73%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $389.24
Upside: +56.46%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $59.15
Upside: +50.46%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $184.38
Upside: +105.01%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $166.45
Upside: +32.17%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $194.61
Upside: -22.92%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $23.30
Upside: +11.61%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $13.69
Upside: +155.66%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $402.27
Upside: +45.42%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $24.52
Upside: -75.53%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $7.73
Upside: +3.49%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $291.28
Upside: +12.95%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $3.50
Upside: -14.29%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $7.21
Upside: +135.78%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $191.40
Upside: -89.55%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $23.01
Upside: -13.08%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.80
Upside: -